Logo image of CDRE

CADRE HOLDINGS INC (CDRE) Stock Fundamental Analysis

USA - NYSE:CDRE - US12763L1052 - Common Stock

34.15 USD
-0.15 (-0.44%)
Last: 9/19/2025, 12:20:02 PM
Fundamental Rating

6

CDRE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 69 industry peers in the Aerospace & Defense industry. While CDRE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CDRE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CDRE was profitable.
In the past year CDRE had a positive cash flow from operations.
CDRE had positive earnings in each of the past 5 years.
In the past 5 years CDRE always reported a positive cash flow from operatings.
CDRE Yearly Net Income VS EBIT VS OCF VS FCFCDRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

The Return On Assets of CDRE (4.80%) is better than 66.67% of its industry peers.
CDRE has a better Return On Equity (11.46%) than 76.81% of its industry peers.
CDRE's Return On Invested Capital of 7.10% is fine compared to the rest of the industry. CDRE outperforms 65.22% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CDRE is in line with the industry average of 8.29%.
Industry RankSector Rank
ROA 4.8%
ROE 11.46%
ROIC 7.1%
ROA(3y)5.33%
ROA(5y)6.73%
ROE(3y)11.56%
ROE(5y)96.32%
ROIC(3y)8.67%
ROIC(5y)11.97%
CDRE Yearly ROA, ROE, ROICCDRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 200 300 400

1.3 Margins

The Profit Margin of CDRE (6.65%) is better than 66.67% of its industry peers.
In the last couple of years the Profit Margin of CDRE has grown nicely.
The Operating Margin of CDRE (12.22%) is better than 78.26% of its industry peers.
CDRE's Operating Margin has improved in the last couple of years.
The Gross Margin of CDRE (41.49%) is better than 84.06% of its industry peers.
In the last couple of years the Gross Margin of CDRE has grown nicely.
Industry RankSector Rank
OM 12.22%
PM (TTM) 6.65%
GM 41.49%
OM growth 3Y-0.25%
OM growth 5Y8.48%
PM growth 3Y28.91%
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y3.46%
CDRE Yearly Profit, Operating, Gross MarginsCDRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CDRE is destroying value.
Compared to 1 year ago, CDRE has more shares outstanding
The number of shares outstanding for CDRE has been increased compared to 5 years ago.
CDRE has a worse debt/assets ratio than last year.
CDRE Yearly Shares OutstandingCDRE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CDRE Yearly Total Debt VS Total AssetsCDRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

CDRE has an Altman-Z score of 3.27. This indicates that CDRE is financially healthy and has little risk of bankruptcy at the moment.
CDRE has a Altman-Z score of 3.27. This is comparable to the rest of the industry: CDRE outperforms 50.72% of its industry peers.
The Debt to FCF ratio of CDRE is 9.51, which is on the high side as it means it would take CDRE, 9.51 years of fcf income to pay off all of its debts.
CDRE has a Debt to FCF ratio of 9.51. This is in the better half of the industry: CDRE outperforms 60.87% of its industry peers.
A Debt/Equity ratio of 0.91 indicates that CDRE is somewhat dependend on debt financing.
CDRE has a worse Debt to Equity ratio (0.91) than 72.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 9.51
Altman-Z 3.27
ROIC/WACC0.73
WACC9.68%
CDRE Yearly LT Debt VS Equity VS FCFCDRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 3.59 indicates that CDRE has no problem at all paying its short term obligations.
CDRE's Current ratio of 3.59 is fine compared to the rest of the industry. CDRE outperforms 78.26% of its industry peers.
CDRE has a Quick Ratio of 2.56. This indicates that CDRE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.56, CDRE is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.59
Quick Ratio 2.56
CDRE Yearly Current Assets VS Current LiabilitesCDRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

CDRE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.74%.
CDRE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 34.28% yearly.
CDRE shows a small growth in Revenue. In the last year, the Revenue has grown by 7.66%.
Measured over the past years, CDRE shows a small growth in Revenue. The Revenue has been growing by 6.17% on average per year.
EPS 1Y (TTM)-8.74%
EPS 3Y34.28%
EPS 5YN/A
EPS Q2Q%-3.23%
Revenue 1Y (TTM)7.66%
Revenue growth 3Y9.92%
Revenue growth 5Y6.17%
Sales Q2Q%8.87%

3.2 Future

The Earnings Per Share is expected to grow by 19.48% on average over the next years. This is quite good.
CDRE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.99% yearly.
EPS Next Y38.27%
EPS Next 2Y26.11%
EPS Next 3Y19.48%
EPS Next 5YN/A
Revenue Next Year11.34%
Revenue Next 2Y9.51%
Revenue Next 3Y8.99%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CDRE Yearly Revenue VS EstimatesCDRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CDRE Yearly EPS VS EstimatesCDRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 36.33, which means the current valuation is very expensive for CDRE.
Based on the Price/Earnings ratio, CDRE is valued a bit cheaper than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, CDRE is valued a bit more expensive.
CDRE is valuated rather expensively with a Price/Forward Earnings ratio of 23.86.
Based on the Price/Forward Earnings ratio, CDRE is valued a bit cheaper than 68.12% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CDRE to the average of the S&P500 Index (22.88), we can say CDRE is valued inline with the index average.
Industry RankSector Rank
PE 36.33
Fwd PE 23.86
CDRE Price Earnings VS Forward Price EarningsCDRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CDRE is valued a bit cheaper than 68.12% of the companies in the same industry.
71.01% of the companies in the same industry are more expensive than CDRE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 41.52
EV/EBITDA 18.24
CDRE Per share dataCDRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

CDRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CDRE may justify a higher PE ratio.
A more expensive valuation may be justified as CDRE's earnings are expected to grow with 19.48% in the coming years.
PEG (NY)0.95
PEG (5Y)N/A
EPS Next 2Y26.11%
EPS Next 3Y19.48%

4

5. Dividend

5.1 Amount

CDRE has a Yearly Dividend Yield of 1.17%.
Compared to an average industry Dividend Yield of 1.47, CDRE pays a better dividend. On top of this CDRE pays more dividend than 88.41% of the companies listed in the same industry.
With a Dividend Yield of 1.17, CDRE pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.17%

5.2 History

CDRE has been paying a dividend for over 5 years, so it has already some track record.
CDRE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years3
CDRE Yearly Dividends per shareCDRE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

38.92% of the earnings are spent on dividend by CDRE. This is a low number and sustainable payout ratio.
DP38.92%
EPS Next 2Y26.11%
EPS Next 3Y19.48%
CDRE Yearly Income VS Free CF VS DividendCDRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 20M 40M 60M
CDRE Dividend Payout.CDRE Dividend Payout, showing the Payout Ratio.CDRE Dividend Payout.PayoutRetained Earnings

CADRE HOLDINGS INC

NYSE:CDRE (9/19/2025, 12:20:02 PM)

34.15

-0.15 (-0.44%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners69.4%
Inst Owner Change-0.36%
Ins Owners30.6%
Ins Owner Change0.05%
Market Cap1.39B
Analysts78.46
Price Target39.27 (14.99%)
Short Float %6.84%
Short Ratio6.61
Dividend
Industry RankSector Rank
Dividend Yield 1.17%
Yearly Dividend0.36
Dividend Growth(5Y)N/A
DP38.92%
Div Incr Years1
Div Non Decr Years3
Ex-Date08-01 2025-08-01 (0.095)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.6%
Min EPS beat(2)11.29%
Max EPS beat(2)87.91%
EPS beat(4)3
Avg EPS beat(4)27.62%
Min EPS beat(4)-31.8%
Max EPS beat(4)87.91%
EPS beat(8)6
Avg EPS beat(8)20.75%
EPS beat(12)8
Avg EPS beat(12)16%
EPS beat(16)10
Avg EPS beat(16)32.32%
Revenue beat(2)2
Avg Revenue beat(2)2.38%
Min Revenue beat(2)0.27%
Max Revenue beat(2)4.48%
Revenue beat(4)3
Avg Revenue beat(4)-2.33%
Min Revenue beat(4)-15.05%
Max Revenue beat(4)4.48%
Revenue beat(8)6
Avg Revenue beat(8)0.05%
Revenue beat(12)9
Avg Revenue beat(12)0.71%
Revenue beat(16)11
Avg Revenue beat(16)0.59%
PT rev (1m)-9.77%
PT rev (3m)-12.17%
EPS NQ rev (1m)-12.79%
EPS NQ rev (3m)-23.74%
EPS NY rev (1m)-1.5%
EPS NY rev (3m)-2.01%
Revenue NQ rev (1m)-1.5%
Revenue NQ rev (3m)-6.26%
Revenue NY rev (1m)-0.67%
Revenue NY rev (3m)-0.66%
Valuation
Industry RankSector Rank
PE 36.33
Fwd PE 23.86
P/S 2.42
P/FCF 41.52
P/OCF 36.09
P/B 4.18
P/tB 43.96
EV/EBITDA 18.24
EPS(TTM)0.94
EY2.75%
EPS(NY)1.43
Fwd EY4.19%
FCF(TTM)0.82
FCFY2.41%
OCF(TTM)0.95
OCFY2.77%
SpS14.08
BVpS8.18
TBVpS0.78
PEG (NY)0.95
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.8%
ROE 11.46%
ROCE 10.17%
ROIC 7.1%
ROICexc 8.87%
ROICexgc 19.55%
OM 12.22%
PM (TTM) 6.65%
GM 41.49%
FCFM 5.84%
ROA(3y)5.33%
ROA(5y)6.73%
ROE(3y)11.56%
ROE(5y)96.32%
ROIC(3y)8.67%
ROIC(5y)11.97%
ROICexc(3y)11.24%
ROICexc(5y)14.1%
ROICexgc(3y)24.24%
ROICexgc(5y)30.41%
ROCE(3y)12.41%
ROCE(5y)17.14%
ROICexcg growth 3Y-11.18%
ROICexcg growth 5Y5.68%
ROICexc growth 3Y-14.82%
ROICexc growth 5Y2.49%
OM growth 3Y-0.25%
OM growth 5Y8.48%
PM growth 3Y28.91%
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y3.46%
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 9.51
Debt/EBITDA 3.49
Cap/Depr 30.73%
Cap/Sales 0.88%
Interest Coverage 4.33
Cash Conversion 44.54%
Profit Quality 87.78%
Current Ratio 3.59
Quick Ratio 2.56
Altman-Z 3.27
F-Score5
WACC9.68%
ROIC/WACC0.73
Cap/Depr(3y)35.32%
Cap/Depr(5y)31.71%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.04%
Profit Quality(3y)322.36%
Profit Quality(5y)273.24%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.74%
EPS 3Y34.28%
EPS 5YN/A
EPS Q2Q%-3.23%
EPS Next Y38.27%
EPS Next 2Y26.11%
EPS Next 3Y19.48%
EPS Next 5YN/A
Revenue 1Y (TTM)7.66%
Revenue growth 3Y9.92%
Revenue growth 5Y6.17%
Sales Q2Q%8.87%
Revenue Next Year11.34%
Revenue Next 2Y9.51%
Revenue Next 3Y8.99%
Revenue Next 5YN/A
EBIT growth 1Y6.25%
EBIT growth 3Y9.65%
EBIT growth 5Y15.18%
EBIT Next Year76.73%
EBIT Next 3Y30.01%
EBIT Next 5YN/A
FCF growth 1Y-26.08%
FCF growth 3Y-11.18%
FCF growth 5Y43.24%
OCF growth 1Y-22.52%
OCF growth 3Y-7.45%
OCF growth 5Y33.8%